Perceptual Disorders: Clinical Trials

252 trials for Perceptual Disorders, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

150 completed, 28 unknown, 22 terminated, 21 recruiting. 252 Phase 2, 52 Phase 3, 27 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 2252Completed 150, Unknown 28, Terminated 22, Recruiting 21, Not yet recruiting 14, Withdrawn 9, Active not recruiting 4, Enrolling by invitation 3, Suspended 1
Phase 352Completed 29, Unknown 10, Terminated 4, Recruiting 3, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1, Suspended 1, Withdrawn 1
Phase 127Completed 11, Recruiting 4, Not yet recruiting 3, Unknown 3, Active not recruiting 2, Terminated 2, Withdrawn 2

Follow Perceptual Disorders: new trials by email Literature Review of Perceptual Disorders trials Research Report on Perceptual Disorders

Trials (filtered) newest first · largest first

All 252 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dexmedetomidine for Invasive Ventilation In the NEOnate
Dexmedetomidine Injectable Solution, Glucose 5% Injectable Solution - Invasive Ventilation, Infant Pain
Phase 2 / Phase 3Not yet recruitingCentre Hospitalier Intercommunal Creteil2462027-01-012026-08-26
Safety of F14 Following Total Knee Replacement
F14 (sustained release celecoxib) - Analgesia
Phase 2 / Phase 3SuspendedArthritis Innovation Corporation1002027-01-012026-06-05
A Clinical Trial of MK-6916 in Participants With Pain After Bunion Removal Surgery (MK-6916-007)
MK-6916, Hydrocodone/acetaminophen (HB/APAP), MK-6916 Placebo - Pain Management
Phase 2Not yet recruitingMerck Sharp & Dohme LLC3802026-11-232026-11-06
Genistein for the Reduction of Adverse Cardiovascular Events (GRACE)
Genistein (Unconjugated Isoflavones 100), Placebo - HIV, Vascular Disease
Phase 1 / Phase 2Not yet recruitingLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's602026-09-302026-08-25
Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults
Sub-dissociative Ketamine Infusion, Normal Saline Placebo Infusion - Sickle Cell Disease, Vaso-Occlusive Pain Episode in Sickle Cell Disease
Phase 2RecruitingMohsen Saidinejad1202026-09-102026-09-02
Fentanyl Intranasal for Retinopathy of Prematurity Screening in Preterm Infants
Fentanyl Citrate (Intranasal), Normal Saline (Placebo, Intranasal) - Neonatal Pain, Retinopathy of Prematurity (ROP)
Phase 1 / Phase 2Not yet recruitingMarsha Campbell-Yeo582026-09-092026-06-30
Efficacy and Safety of Anrikefon Injection for the Treatment of Postoperative Pain in Patients Undergoing Laparoscopic Hepatectomy
Anrikefon Injection, Flurbiprofen - Pain Management
Phase 2Not yet recruitingTianjin Medical University Cancer Institute and Hospital1082026-09-012026-09-17
Effect of Opioid-Sparing Anesthesia on Postoperative Opioid Consumption and Pain in Elderly Patients Undergoing Spine Surgery
Opioid-Sparing Protocol, Routine anesthesia protocol - Opoid Managment, Pain Management
Phase 2Not yet recruitingMassachusetts General Hospital1202026-09-012026-09-08
The Use of Photobiomodulation for Pain and Healing in Cesarean Section
Photobiomodulation (PBM), Placebo PBM, Standard Hospital Treatment - Post Partum, Cesarean Birth
Phase 2Not yet recruitingUniversity of Nove de Julho302026-09-012026-09-08
Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain
Canadá, Canadá placebo, Dipyrone - Pain, Chronic
Phase 2WithdrawnEMS2026-09-012023-09-08
Paracervical Block With Combined Ketorolac and Lidocaine for Osmotic Dilator Placement
Ketorolac, oral ibuprofen, Placebo - Pain Management, Abortion
Phase 2RecruitingRush University Medical Center762026-06-292026-07-06
Pilot Randomized Control Trial Comparing Oral Ketamine and Oral Oxycodone for Pain Control in Emergency Department Patients
oral ketamine, oxycodone - Pain Management
Phase 2 / Phase 3Not yet recruitingAlbany Medical College602026-06-242026-06-26
Phase II, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Omega-3 Fatty Acids as an Adjunct to Morphine in Acute Postoperative Pain
Omega-3 fatty acids + Morphine group, Placebo+ Morphine group - Pain Postoperative, Analgesia
Phase 2Not yet recruitingNational University of La Rioja402026-06-152026-06-18
Buprenorphine for Analgesia in Older Adults With Acute Fractures in the Emergency Department
Buprenorphine 0.15 MG, Hydromorphone 0.25 mg IV - Fracture
Phase 1 / Phase 2RecruitingThe Cooper Health System482026-05-072026-06-29
Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study
Cannabidiol (CBD) oral solution, Full-Spectrum CBD hemp extract oral solution, Placebo in MCT oil oral solution - Diabetic Peripheral Neuropathic Pain (DPN), Diabetic Neuropathies
Phase 1 / Phase 2RecruitingFlorida A&M University202026-04-022026-04-29
An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
ML-007C-MA - Psychosis Associated With Alzheimer's Disease
Phase 2Enrolling by invitationMapLight Therapeutics2102026-03-252026-11-12
Sciatic Nerve Block With ALX006 in Subjects Undergoing Bunionectomy
ALX006 (bupivacaine extended-release injection), Bupivacaine Hcl 0.25% Inj, Sciatic Nerve Block - Hallux Valgus, Bunionectomy
Phase 2RecruitingRebel Medicine Inc602026-03-102026-05-07
Prospective IR-led Sedation Feasibility
ketamine, Fentanyl (IV), Midazolam - Anesthesia, Sedation and Analgesia
Phase 1 / Phase 2RecruitingCAMC Health System402026-03-022026-03-09
Evaluation of the Efficacy and Onset of Action of a Topical Anesthetic Marker
Cutaneous marker (Transcutol P+ 20%, Tetracaine 7%, Lidocaine 23%, and dye q.s.), - Pain Management
Phase 2Not yet recruitingHexsel Dermatology Clinic202026-03-012025-12-10
Sufentanil Versus Ketamine Intranasally in the Management of Severe Acute Trauma-related Pain in Children.
Intranasal Sufentanil, Intranasal Ketamine (IN) - Traumatology, Wounds and Injury
Phase 2Not yet recruitingFondation Lenval1162026-02-052026-01-28

Showing 20 of 252. Sign in to see all of them.

Narrower conditions

Agnosia (223)  ·  Pain (59)  ·  Pain, Postoperative (51)  ·  Hallucinations (20)  ·  Neuralgia (13)  ·  Chronic Pain (12)  ·  Acute Pain (11)  ·  Schizophrenia (11)  ·  Psychotic Disorders (9)  ·  Delusions (8)  ·  Osteoarthritis (7)  ·  Opioid-Related Disorders (6)  ·  Phantom Limb (6)  ·  Bunion (5)  ·  Diabetic Neuropathies (5)

Broader conditions

Neurobehavioral Manifestations (252)  ·  Pathological Conditions, Signs and Symptoms (252)  ·  Signs and Symptoms (252)  ·  Neurologic Manifestations (251)  ·  Nervous System Diseases (250)  ·  Pain (70)  ·  Pathologic Processes (69)  ·  Postoperative Complications (56)  ·  Mental Disorders (29)  ·  Musculoskeletal Diseases (24)  ·  Neuromuscular Diseases (21)  ·  Central Nervous System Diseases (18)  ·  Peripheral Nervous System Diseases (17)  ·  Neoplasms (15)

Interventions

Bupivacaine (21)  ·  Acetaminophen (18)  ·  Dexmedetomidine (14)  ·  Ropivacaine (12)  ·  Fentanyl (11)  ·  Ibuprofen (11)  ·  Saline Solution (11)  ·  Lidocaine (10)  ·  Morphine (10)  ·  Sodium Chloride (9)  ·  Epinephrine (7)  ·  Ketamine (7)  ·  Hydromorphone (6)  ·  Oxycodone (6)  ·  Dexamethasone (5)

Sponsors

Assiut University (10)  ·  Pacira Pharmaceuticals, Inc (7)  ·  Baudax Bio (4)  ·  Heron Therapeutics (4)  ·  ACADIA Pharmaceuticals Inc. (3)  ·  Ain Shams Maternity Hospital (3)  ·  Ain Shams University (3)  ·  Asklepieion Voulas General Hospital (3)  ·  AstraZeneca (3)  ·  Johns Hopkins University (3)  ·  Massachusetts General Hospital (3)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (3)  ·  Novartis Pharmaceuticals (3)  ·  University of Chicago (3)  ·  Wake Forest University Health Sciences (3)

Countries

United States (112)  ·  Canada (19)  ·  Egypt (17)  ·  France (11)  ·  China (10)  ·  Brazil (8)  ·  Germany (7)  ·  Italy (5)  ·  United Kingdom (5)  ·  Bulgaria (4)  ·  Denmark (4)  ·  Greece (4)  ·  Israel (4)  ·  South Korea (4)  ·  Spain (4)

Top investigators

Claudia Campbell, PhD (3)  ·  James Zacny, Ph.D. (3)  ·  Kay Warnott, RN, ACNP (3)  ·  Biljana Lilja (2)  ·  Christine N. Sang, MD, MPH (2)  ·  David H Chi, MD (2)  ·  Erol Onel, MD (2)  ·  Ilise Lombardo, MD (2)  ·  Joseph H. Atkinson, MD (2)  ·  Na Li, MD (2)  ·  Neil Singla, MD (2)  ·  Philip Wilson, MD (2)  ·  Sergey Motov, MD (2)

Results publications

PMID 22900785, PMID 11133630, PMID 12298311, PMID 12411815, PMID 12873949, PMID 12934209, PMID 1517644, PMID 15513495, PMID 15919269, PMID 16452738, PMID 16521220, PMID 16651569, PMID 17341537, PMID 17414235, PMID 18042413, PMID 18191686, PMID 18311814, PMID 18388680, PMID 18442107, PMID 18591063, PMID 18648238, PMID 19151049, PMID 19214642, PMID 19520544, PMID 19524477, PMID 19535720, PMID 19740486, PMID 1977542, PMID 20012652, PMID 20962287, PMID 20975464, PMID 21368651, PMID 21562445, PMID 21674151, PMID 21765198, PMID 21921019, PMID 22013534, PMID 22227789, PMID 22955296, PMID 23049275, PMID 23241361, PMID 23485015, PMID 23611363, PMID 2367246, PMID 23934921, PMID 24054878, PMID 24399578, PMID 24550805, PMID 24806873, PMID 25175864

NIH funding

2019 (3), 2025 (3), R01DA008391 (3), 2008 (2), R01NS041503 (2), 2009 (1), K01AT001111 (1), P01NS119159 (1), P30CA012197 (1), P50DA009236 (1), R01AG047146 (1), R01AR045506 (1), R01DA030424 (1), R01DA040644 (1), R01MH073673 (1)